Cybin Inc. (HELP)

Cybin Inc. (HELP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $799M; returns 1 day -3.0%, 1 week -3.4%.

Cybin Inc. is a clinical-stage neuropsychiatry company focused on developing next-generation psychedelic-based therapeutics for mental health disorders. As of early 2026, the company operates without traditional product revenue, relying entirely on capital markets to fund its intensive R&D pipeline.

Groups HELP belongs to

• Biotechnology
• Clinical Stage Biotech
• Canada Companies
• Neuroscience
• Mental Health Solutions
• CNS Disorders
• Healthcare
• Life Sciences
• Clinical Stage
• Pharmaceuticals
• Drug Discovery
• R&D
• Healthcare Innovation
• Canada

HELP financial model: income statement, cash flow and balance sheet